This Newsletter covers Federal and State policy and legislative developments in the area of health. Copies of documents referred to can be obtained by clicking on the reference in this Newsletter or through Capital Monitor's collection at www.capitalmonitor.com.au or from the source quoted.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
24 August
Australian Public Assessment Report for Crizanlizumab
The Department of Health released an AusPAR for the application by Novartis Pharmaceuticals Australia Pty Ltd (the sponsor) to register Adakveo (crizanlizumab) 10 mg/mL concentrate for solution for infusion vial for the following proposed indication: for the prevention of vaso-occlusive crises in sickle cell disease patients. The proposed dosage is 5 mg/kg by intravenous infusion over 30 minutes at Week 0, Week 2 and every 4 weeks thereafter.
Download
23 August
ATAGI update following weekly COVID-19 meeting
The Department of Health said that ATAGI met on Wednesday 18 August 2021 to review the latest developments relating to COVID-19 and COVID-19 vaccine safety. In addition, ATAGI continues to monitor COVID-19 epidemiology in Australia including current COVID-19 outbreaks involving the Delta variant, including in New South Wales, Australian Capital Territory and Victoria. ATAGI stresses that vaccination is a key public health intervention to prevent infection, transmission and severe disease. ATAGI continues to recommend COVID-19 vaccination for all adults, and specific high-risk adolescents.
Download
New CSIRO study reveals why personality matters for weight loss
CSIRO Scientists have found Australia is a nation of 'Thinkers' and 'Battlers', in the nation's largest personality and weight loss study. In an update to the 2017 Diet Types study, researchers from CSIRO, Australia's national science agency, studied over 245,000 people to understand the unique behavioural and emotional characteristics that might be helping or hindering the national waistline in 2021. The recent study identified 325 possible Diet Type personality combinations, including two new hybrid personalities, the 'Battler' and the 'Pleaser', representing around 20 per cent of all dieters.
Download
Perils for doctors as well as patients in fragmented general practice care
The Medical Journal of Australia (MJA) said that fragmented patient care in general practice can lead to missed diagnoses, inappropriate prescribing, failure of preventive medicine, and subsequent medico-legal consequences for doctors, according to a Perspective published by the Medical Journal of Australia. The authors, led by Dr Jack Marjot, Medical Advisor with Avant Mutual, Australia's largest medical defence organisations, wrote that continuity of care referred to 'the holistic management of a patient by a single practitioner, or a well integrated network of practitioners in close communication'.
Download
Increased breast cancer detection rates quantified for five risk factors
The age-specific impact of risk factors on breast cancer detection at regular screens and between screens could inform discussions of risk-stratified screening, according to research published by the Medical Journal of Australia. 'The aim of risk-stratified screening is to potentially improve the benefit and possibly reduce the harms of screening by reducing the interval between screens, or by using more sensitive imaging procedures for people at higher risk while reducing screening intensity for those at lower risk,' wrote the authors, led by Dr Naomi Noguchi from the School of Public Health at the University of Sydney.
Download
GPs gaining confidence in prescribing for Hep C
The broad prescribing authority for direct-acting antivirals for hepatitis C has allowed a large number of general practitioners to take part, increasing GP confidence and improving care for their patients, according to research published by the Medical Journal of Australia. Direct-acting antiviral (DAA) therapy has been available for people with chronic hepatitis C through the Pharmaceutical Benefits Scheme (PBS) since March 2016, and all clinicians, including GPs, can prescribe. Authors led by Dr Behzad Hajarizadeh, a Senior Lecturer at the Kirby Institute, analysed PBS data for DAA dispensed to people with chronic hepatitis C during March 2016.
Download
New research on boosting killer immune response to cancer
The National Health and Medical Research Centre (NHMRC) said that drugs already approved and available could be the answer to boost the production of killer T cells and improve the success rate of immunotherapies for cancer. Dr Ian Parish, who holds a joint position in cancer immunology at the Peter MacCallum Cancer Centre and the University of Melbourne, received a four-year $1,154,196 Ideas Grant to investigate the repurposing of a drug to increase the number of patients who respond to cancer immunotherapy. 'Immunotherapies have emerged as a revolutionary treatment for cancer in the last 10 years,' Dr Parish said.
Download
Return to top
Research
24 August
Modelling highlights risk in national COVID plan
Australia's National Plan to relax COVID-19 restrictions puts too many lives at risk and could hamper thousands more Australians with ongoing illness, according to new modelling from researchers. The researchers argue that at least 90 per cent of all Australians, including children, must be vaccinated against COVID-19 before fully relaxing public health measures and opening the international border. Professor Quentin Grafton from the Australian National University, Dr Zoë Hyde from the University of Western Australia and Professor Tom Kompas from the University of Melbourne examined the Australian Government's National Plan to reduce restrictions once enough adults are vaccinated.
Download
23 August
VIC: A step closer to Victoria's first mRNA COVID-19 vaccine
With clinical trials of Australia's first mRNA coronavirus vaccine due to start in coming months, a key piece of equipment has arrived in Victoria to enable the critical manufacturing capability of mRNA vaccines to commence. A new $1 million NanoAssemblr machine has been shipped in from Canada and will allow Boronia-based company IDT Australia to create the final product for mRNA vaccines. It is the only machine of its kind in Australia and can process nanoparticles into final liquid drug form, sterilise the product and fill vials with mRNA vaccines, said Victorian Minister for Medical Research Jaala Pulford.
Download
20 August
$79 million to turn brilliant ideas into new treatments
The Government is investing $79 million in medical research and innovation projects to develop new medical devices, medicines, and digital health technologies, which will benefit Australians who need them. Australia's researchers are world leading, however many of their great ideas do not always receive the support needed to make the transition into practice. The Medical Research Future Fund's Medical Research Commercialisation initiative addresses this gap to help great ideas become products, which benefit patients in Australia and around the world. The $79 million will be shared among four companies with established track records in identifying and nurturing exciting new biomed tech ideas, said Minister for Health and Aged Care Greg Hunt.
Download
Return to top
Rural, Regional and Remote Health
23 August
'Deafening silence' from SA Health as rural doctors left out on a (breaking) limb
South Australia's leading doctors' groups have urged SA Health to urgently respond to them with a fairer reform package for rural GP VMOs (Visiting Medical Officers), or risk the further loss of healthcare services for rural South Australians. A survey of the state's rural doctors shows a critical shortage of doctors is threatening the future of hospital and GP services in rural South Australia. A member forum held by the Rural Doctors Association of South Australia (RDASA) at the weekend also raised significant concerns by SA rural doctors at worsening medical workforce shortages across rural South Australia - both in rural general practices and also in the state's rural hospitals.
Download
Return to top
Women's Health
23 August
Increased breast cancer detection rates quantified for five risk factors
The age-specific impact of risk factors on breast cancer detection at regular screens and between screens could inform discussions of risk-stratified screening, according to research published by the Medical Journal of Australia. 'The aim of risk-stratified screening is to potentially improve the benefit and possibly reduce the harms of screening by reducing the interval between screens, or by using more sensitive imaging procedures for people at higher risk while reducing screening intensity for those at lower risk,' wrote the authors, led by Dr Naomi Noguchi from the School of Public Health at the University of Sydney.
Download
Return to top
Transcripts
Prime Minister Scott Morrison, Minister for Health Greg Hunt and Minister for Foreign Affairs Marise Payne
26 AUG: Transcript of Press Conference, Canberra
Subjects: ATAGI, Vaccine rollout, National Security Committee of Cabinet, Situation in Afghanistan, Delta strain, Vaccine national targets
Minister for Agriculture, Drought and Emergency Management Australia Bridget McKenzie and Deputy Leader of the Australian Labor Party Richard Marles
26 AUG: Transcript of Interview with Matt Doran, ABC Capital Hill
Subjects: COVID, Teenage vaccination, National Plan, PM, Afghanistan, AstraZeneca, ACT, Mental health, Economic stress
Minister for Finance Simon Birmingham
26 AUG: Transcript of Interview with Steve Austin, ABC Brisbane, Drive
Subjects: Qld, Quarantine facility, International flights, COVID, Vaccination, Doherty modelling, Pfizer, Moderna
Minister for Education and Youth Alan Tudge
26 AUG: Transcript of Interview with Fran Kelly, Radio National
Subjects: Return of students to classrooms, Vaccinating young Australians, Children's Commissioner, Vaccine rollout, Vaccine targets, ATAGI advice, Vaccinating teachers
Australian Medical Association (AMA)
26 AUG: Transcript of President, Dr Omar Khorshid's Interview with Fran Kelly, RN Breakfast
Subjects: Hospitals, Health system, COVID cases, Vaccines, Vaccine passport, QLD
Australian Medical Association (AMA)
26 AUG: Transcript of President, Dr Omar Khorshid's Interview with Fran Kelly, RN Breakfast
Subjects: Hospitals, Health system, COVID cases, Vaccines, Vaccine passport, QLD
Leader of the Opposition Anthony Albanese
26 AUG: Transcript of Interview with Phil Ackman, Cairns FM 89.1
Subjects: Fed election, Fed Govt, PM, COVID outbreaks, Lockdowns, Vaccine rollout, Vaccine incentive, Fed Opp's policy agenda, Women's safety, Climate change, Afghanistan
Leader of the Opposition Anthony Albanese
26 AUG: Transcript of Interview with Angela Walsh, 2ST Highlands Mornings
Subjects: National plan, Doherty modelling, COVID outbreaks around Australia, Lockdowns, Vaccine rollout, Quarantine facilities, Fed Opp's vaccine incentive
Leader of the Opposition Anthony Albanese
26 AUG: Transcript of Interview with Angela Walsh, 2ST Highlands Mornings
Subjects: National plan, Doherty modelling, Australian COVID outbreaks, Lockdowns, Vaccine rollout, National quarantine facilities, Fed Opp's vaccine incentive
Shadow Minister for Health and Ageing Mark Butler
26 AUG: Transcript of Interview with Patricia Karvelas, ABC Afternoon Briefing
Subjects: Vaccination targets, Vaccine freedoms, Hospitalisations, NSW, Teenage vaccinations, National plan
Shadow Minister for Health and Ageing Mark Butler
26 AUG: Transcript of Doorstop Interview, Adelaide
Subjects: Australia's worst days in the COVID-19 pandemic, ICU admission rates, Third wave, Vaccine rollout, Quarantine systems, Teenage vaccination, National Cabinet
Shadow Minister for the National Disability Insurance Scheme Bill Shorten
26 AUG: Transcript of Interview with Paul Turton, ABC Radio Newcastle
Subjects: Disability Services Australia voluntary administration, NDIS, Doherty Institute modelling, NDIS Quality and Safeguards Commission, COVID-19
Shadow Minister for Industrial Relations Tony Burke
26 AUG: Transcript of Interview with Laura Jayes, Sky News
Subjects: Western Sydney COVID outbreak, Delta variant, Doherty modelling, Vaccine rollout, National plan, Quarantine, Health system
Shadow Minister for Indigenous Australians Linda Burney
26 AUG: Transcript of Interview with Ray Hadley, 2GB
Subjects: COVID-19, First Nations communities, Regions, Pharmacies, Supermarkets, Hospitals, Vaccines, AstraZeneca, Pfizer
Shadow Minister for Indigenous Australians Linda Burney
26 AUG: Transcript of Interview with Thomas Oriti, ABC News Radio Breakfast
Subjects: Lockdown in south west Sydney, The Morrison Government, COVID outbreaks in Indigenous communities, Vaccine clinics, Vaccine rollout, Easing of restrictions
Labor Member for Oxley Milton Dick
26 AUG: Transcript of Interview with Laura Jayes, Sky News
Subjects: Question Time reform, Question Time error, Quarantine, Vaccines, PM
Prime Minister Scott Morrison
25 AUG: Transcript of Interview with Ray Hadley, 2GB
Subjects: Queensland travel restrictions, Doherty Institute, National plan, Vaccine rollout, Vaccine targets, Vaccine hesitancy, Construction industry, Brereton Report
Treasurer Josh Frydenberg
25 AUG: Transcript of Interview with Ben Fordham, 2GB
Subjects: SME loans, Vaccine rollout, Economic support, Loan repayments, Economy, Small business, Rewarding vaccinated Australians, Doherty Institute
Treasurer Josh Frydenberg
25 AUG: Transcript of Interview with Michael Rowland, ABC News Breakfast
Subjects: SME Support, Vaccination, Vaccine rollout, Mandatory vaccinations, Aged care workers, Western Australian Premier, Doherty Institute
Treasurer Josh Frydenberg
25 AUG: Transcript of Interview with Leon Byner, FIVEaa
Subjects: Small business support, Lockdowns, Vaccination, Loan repayment, Tourism sector, Hospitality sector, Vaccine rollout
Treasurer Josh Frydenberg
25 AUG: Transcript of Interview with Neil Mitchell, 3AW
Subjects: Lockdowns, Vaccine rollout, Economic support, Small business support, Iron ore, China, Loan repayments, Doherty Institute, Superannuation
Treasurer Josh Frydenberg
25 AUG: Transcript of Interview with Peter Stefanovic, Sky News
Subjects: Small business support, Vaccination, Debt, Vaccine targets, National plan, State Premiers, Doherty Institute, Lockdowns
Minister for Regional Health David Gillespie
25 AUG: Transcript of Interview with Steve Price, Triple M
Subjects: Vaccine rollout, Effectiveness of masks, Regional Australia COVID outbreaks, Teacher shortage, National plan, Lockdowns
Minister for Finance Simon Birmingham
25 AUG: Transcript of Interview with Patricia Karvelas, ABC News, Afternoon Briefing
Subjects: National COVID plan, Lockdowns, Vaccine targets, Doherty Institute, Financial support, Vaccine rollout, QLD travel restrictions
Liberal Member for Lindsay Melissa McIntosh and Labor Senator for South Australia Marielle Smith
25 AUG: Transcript of Interview with Matthew Doran, ABC Capital Hill
Subjects: COVID-19, Vaccination rollout, Afghanistan, Mental health, Health system, Prime Minister, Doherty modelling, Vaccine targets, ATAGI advice
Leader of the Opposition Anthony Albanese
25 AUG: Transcript of Interview with Mark Rorke, 2NUR FM103.7
Subjects: PM, Doherty modelling, COVID outbreaks around Australia, Lockdowns, Vaccine rollout, National quarantine facilities, Fed Opp's $300 COVID vaccination incentive
Leader of the Opposition Anthony Albanese
25 AUG: Transcript of Interview with John Laws, 2SM
Subjects: Doherty modelling, COVID outbreaks, Lockdowns, Vaccine rollout, National quarantine facilities, Cash incentive for COVID vaccination
Leader of the Opposition Anthony Albanese
25 AUG: Transcript of Interview with Oliver Peterson, 6PR Perth Live
Subjects: AFL Grand Final, PM, National plan, Doherty modelling, COVID outbreaks around Australia, Vaccine rollout, Fed Opp's vaccination incentive, WA Premier
Leader of the Opposition Anthony Albanese
25 AUG: Transcript of Interview with Dean Clairs & Lisa Shaw, 96FM Perth, The Bunch
Subjects: PM calling Western Australians & Queenslanders cave people, Doherty modelling, COVID-19, Lockdowns, Vaccine rollout, Quarantine facilities
Leader of the Opposition Anthony Albanese
25 AUG: Transcript of Interview with Jenny Marchant & Dan Cox, ABC Newcastle Breakfast
Subjects: Doherty modelling, COVID outbreaks, Lockdowns, Vaccine rollout, Need for national quarantine facilities, Cash incentive for COVID vaccination
Leader of the Opposition Anthony Albanese
25 AUG: Transcript of Interview with Michael Rowland, ABC News Breakfast
Subjects: Doherty modelling, COVID outbreaks around Australia, Lockdowns, Vaccine rollout, Need for national quarantine facilities, Opposition's policy agenda
Leader of the Australian Labor Party in the Senate Penny Wong
25 AUG: Speech to the Senate - 'Prime Minister's new promises to cover old failings'
Subjects: Vaccine rollout, Quarantine, Lockdowns, Aged care workers, First Nations Australians
Shadow Minister for Health and Ageing Mark Butler
25 AUG: Transcript of Doorstop Interview, Adelaide
Subjects: COVID-19 pandemic, Vaccination targets, National plan, Doherty modelling, State borders, Aged care workers vaccination rates, Teenage vaccinations
Shadow Assistant Minister for Treasury Andrew Leigh
25 AUG: Transcript of Doorstop Interview, Parliament House, Canberra
Subjects: JobKeeper, JobKeeper transparency amendment, Economic support, COVID-19 vaccine rollout, Vaccine cash incentive, Vaccination rates
Prime Minister Scott Morrison
24 AUG: Transcript of Interview with David Koch, Sunrise
Subjects: Economy, Lockdown restrictions, Vaccination rollout, Public health, Restrictions, Vaccine rates
Minister for Health Greg Hunt
24 AUG: Transcript of Interview with Sabra Lane, ABC AM
Subjects: COVID-19, Sydney lockdown, Vaccine rollout, Pfizer, AstraZeneca, Young people
Minister for Education Allan Tudge
24 AUG: Transcript of Interview with Stephen Cenatiempo, 2CC
Subjects: National Curriculum, More support for child care centres, Doherty Institute advice on lifting lockdowns
Australian Medical Association (AMA)
24 AUG: Transcript of Vice President, Dr Chris Moy's Interview with Joe O'Brien, ABC News
Subjects: Vaccine rollout, Future, Health System, Sydney lockdown, Masks
Shadow Treasurer Jim Chalmers
23 AUG: Transcript of Interview with Steve Austin, ABC Brisbane Drive
Subjects: Afghanistan, Prime Minister's 3 year anniversary as Prime Minister, COVID-19 vaccination targets, Vaccine rollout
Prime Minister Scott Morrison, Minister for Foreign Affairs Payne and Minister for Health Hunt
23 AUG: Transcript of Press Conference, Canberra
Subjects: Afghanistan, Visa holders, Doherty modelling, Live with the virus, Vaccination, Lockdowns, Mental Health, Economy, NATO
Minister for Foreign Affairs Marise Payne
23 AUG: Transcript of Interview with Adam Shirley, ABC Canberra Mornings
Subjects: COVID-19. Health, Parliamentary sitting, Lockdown, NSW, Sydney
Minister for Home Affairs Karen Andrews
23 AUG: Transcript of Interview with Matt Webber, ABC Gold Coast
Subjects: QLD/NSW border, Queensland Government's border restrictions, COVID-19 vaccine rollout, Public health, Restrictions, Lockdowns
Labor Senator for the Northern Territory Malarndirri McCarthy
23 AUG: Transcript of Interview with Stewart Brash, ABC Alice Springs
Subjects: Government failing First Nations communities in messaging for COVID, Western NSW COVID cases, Community controlled Aboriginal health sector in vaccine rollout
Minister for Employment, Workforce, Skills, Small and Family Business Stuart Robert
23 AUG: Transcript of Interview with Karl Stefanovic and Allison Langdon, The Today Show
Subjects: JobTrainer hits 230,000 enrolments, July unemployment figures, JobKeeper, Australia's national vaccination plan
Assistant Minister to the Attorney-General Amanda Stoker
23 AUG: Transcript of Doorstop Interview, Located Undisclosed
Subjects: Lockdown protests, Vaccination rollout, State borders, National Cabinet, Suppression and elimination strategies
Leader of the Opposition Anthony Albanese
23 AUG: Transcript of Interview with Sally Bryant, ABC Riverina Breakfast
Subjects: COVID outbreaks, Lockdowns, Vaccine rollout, Need for national quarantine facilities, Fed Opp's $300 vaccination incentive, Climate change, Afghanistan
Senator for the Northern Territory Malarndirri McCarthy
23 AUG: Transcript of Interview with Adam Steer and Jo Laverty, ABC Darwin
Subjects: COVID, Vaccine rollout, Remote NT communities, Refugees, Darwin, Detention, Brisbane community, Vaccine hesitancy
The Department of Health
22 AUG: Transcript of Press Conference with Chief Medical Officer, Paul Kelly, Canberra
Subjects: COVID-19 cases across the States, Hospitalisation rates, Vaccination rates, ADF, Doherty modelling, Aged-care workers
Department of Health
21 AUG: Transcript of Press Conference by Deputy Chief Medical Officer, Michael Kidd, Canberra
Subjects: Declaration of all of Victoria as a hotspot, COVID-19 vaccinations across the country, State lockdowns
Shadow Minister for Health and Ageing Mark Butler
21 AUG: Transcript of Doorstop Interview, Adelaide
Subjects: Australia's worst day in the COVID-19 pandemic, Indigenous Australians, Aged care residents, Sydney's third wave, Teenage vaccinations, Vaccine passports, Afghanistan
Minister for Employment, Workforce, Skills, Small and Family Business Stuart Robert
20 AUG: Transcript of Interview with Patricia Karvelas, Patricia Karvelas
Subjects: Unemployment rate, State lockdowns, Youth participation rate, Economic recovery, Vaccination rates, Women's participation rate
Senator for South Australia Marielle Smith
20 AUG: Transcript of Interview with Narelle Graham, ABC SA Regional Drive
Subjects: Ceduna Health Clinic, Closing the Gap, Yadu Health Clinic, First Nations people, First Nations communities, Lack of funding, Public health
Treasurer Josh Frydenberg
19 AUG: Transcript of Interview with Kieran Gilbert, Afternoon Agenda Sky News
Subjects: Labour force, Vaccine rollout, Economic support, Indigenous Australians, Afghanistan, Unemployment rate
Return to top
Reports
PHI 54/21 Revision of ICD-10- AM/ACHI/ACS and AR-DRG Cycles
Department of Health
International Statistical Classification of Diseases and Related Health Problems. Tenth Revision, Australian Modification, Australian Classification of Health Interventions, Australian Coding Standards and Australian Refined Diagnosis Related Groups classification systems extended development cycle. The Independent Hospital Pricing Authority (IHPA) has responsibility for the development and licensing of the following admitted care classification systems:
- Australian Refined Diagnosis Related Groups (AR-DRGs);
- International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification; Australian Classification of Health Interventions; and
- Australian Coding Standards (ICD-10-AM/ACHI/ACS).
Download
COVID -19 Rapid Antigen Point of Care Testing
Department of Health
The purpose of this document is to provide some guidance to businesses who are considering using COVID-19 rapid antigen tests to ensure they understand the key considerations when performing rapid antigen point of care tests (PoCTs). It should be noted that this document is an interim document as further, more detailed guidance on undertaking COVID-19 testing for workplace screening is being developed by the Department of Health.
Download
Australian Public Assessment Report for Influenza Haemagglutinin Recombinant
Department of Health
Download
COVID-19 vaccination - Vaccinations by State - National summary
Department of Health
Download
Minister for Health Employee Engagement Survey 2021 - WA health system Results Report
Department of Health
Download
Testing for toxins in medicinal cannabis products being supplied via SAS B in Australia: TGA Laboratories testing report
Department of Health and Therapeutic Goods Administration (TGA)
The levels at which toxins and impurities must be controlled in medicinal cannabis plant products are defined in Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis) (TGO93). The survey described in this report was conducted to test for the presence of selected toxins as specified in subsection 12(1) of TGO93 for medicinal cannabis plant products.
Download
Testing of paediatric medicinal cannabis products being supplied via SAS in Australia: TGA Laboratories testing report
Department of Health and Therapeutic Goods Administration (TGA)
Some medicinal cannabis products are used in the paediatric population in the management of a number of different indications. These products are permitted to be supplied in Australia under the Special Access Scheme (SAS), Authorised Prescriber scheme, and clinical trial schemes. Products supplied under these schemes are required to comply with Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis) (TGO93).
Download
Medical device inclusion process
Department of Health and Therapeutic Goods Administration (TGA)
Medical devices, including IVD medical devices, are regulated by the Therapeutic Goods Administration (TGA), in accordance with:
- The Therapeutic Goods Act 1989 (the Act)
- The Therapeutic Goods (Medical Devices) Regulations 2002 (the Regulations)
- The Therapeutic Goods Regulations 1990
Download
COVID-19 vaccine weekly safety report - 26-08-2021
Department of Health and Therapeutic Goods Administration (TGA)
Vaccination against COVID-19 is the most effective way to reduce deaths and severe illness from infection. Two COVID-19 vaccines are currently in use in Australia - Vaxzevria (AstraZeneca) and Comirnaty (Pfizer). Recently, the Therapeutic Goods Administration (TGA) granted provisional approval for another vaccine called Spikevax (Moderna). Like all medicines, COVID-19 vaccines have some side effects (also known as adverse events). These side effects need to be continuously balanced against the expected benefits in preventing illness and death from COVID-19 disease. The overwhelming majority of side effects are mild and resolve within a few days.
Download
Australian Public Assessment Report for Upadacitinib
Department of Health and Therapeutic Goods Administration (TGA)
Therapy with Rinvoq (upadacitinib) should be initiated and monitored by a rheumatologist or specialist physician with expertise in the management of the indicated conditions. Rinvoq should not be initiated in patients with an absolute lymphocyte count (ALC) less than 500 cells/mm3, an absolute neutrophil count (ANC) less than 1000 cells/mm3 or who have haemoglobin levels less than 8 g/dL (See Section4.4 Special warnings and precautions for use; and Section 4.8 adverse effects in the Product Information).
Download
Rapid Evidence Review: Violence, abuse, neglect and exploitation of people with disability
Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability
This rapid review - undertaken by the Centre for Evidence and Implementation in partnership with Monash University - reviews evidence that describes experiences of violence, abuse, neglect and exploitation, with the aim of preventing this from occurring, and better supporting people with disability.
Download
Provisional Mortality Statistics
Australian Bureau of Statistics (ABS)
58,515 deaths occurred by 31 May 2021 and were registered by 31 July. Counts of deaths were above historical averages for each month of 2021. Age-standardised mortality rates were below historical averages for each month of 2021.
Download
Supplementary Submission - NDIS National Workforce Plan: 2021-2025
Community Mental Health Australia (CMHA), Mental Illness Fellowship of Australia (MIFA)
and Mental Health Australia
The submission welcomed the development of the NDIS National Workforce Plan: 2021-25. Strategic national planning is required to develop the responsive, compassionate, capable and competent NDIS workforce at the scale required to meet the needs of people with disability, including psychosocial disability.
Download
Corporate Plan 2021-22
Professional Services Review
This document is a four-year plan outlining the purpose, vision, values, strategic drivers, strategic goals, actions and key performance indicators for the Professional Services Review Agency. PSR's purpose is to protect the integrity of the Commonwealth Medicare Benefits, Dental Benefits and Pharmaceutical Benefits programs and to safeguard the Australian public from the cost and risk of inappropriate practice. PSR investigates suspected inappropriate practice by health practitioners, on request from the Chief Executive Medicare.
Download
Disease expenditure in Australia 2018-19
Australian Institute of Health and Welfare (AIHW)
Disease expenditure in Australia 2018-19 describes the activity and characteristics of Australia's health care system in terms of estimated expenditure for different demographic groups in the population, and expenditure relating to different groups of diseases. This web report provides the most recent data available on the health care expenditure on all Australian Burden of Disease Study conditions, including expenditure by health care sector, type of condition, age group, and sex.
Download
Tuberculosis in Australia's tropical north: a population-based genomic epidemiological study
Menzies School of Health Research
The Northern Territory (NT) has the highest rate of TB in Australia, with most cases occurring in those born overseas and in Australian First Nations peoples. The NT lies in close geographic proximity to Southeast Asia, and TB cases have increased with sporadic influxes of arrivals from neighbouring countries. Approximately a third of NT residents are Aboriginal peoples, three quarters of whom live in remote regions. Public health surveillance data suggest that TB rates in NT Aboriginal peoples have dropped markedly but remain consistently higher than in non-Indigenous Australian-born people.
Download
Being Equally Well - A National Policy Roadmap to Better Physical Health Care and Longer Lives for People Living with Serious Mental Illness
Mitchell Institute, Victoria University
Current health care services are simply and starkly failing to provide adequate physical health care for people with serious mental illness. People with serious mental illness have high rates of physical illness, particularly chronic diseases, and a far shorter life expectancy than the general population. This Being Equally Well Roadmap comprises implementable, evidence-based changes that are feasible, affordable, and practical.
Download
2020 Annual Report
Menzies School of Health Research
Download
Return to top
Hansards
Federal
26 AUG 2021: REPS HANSARD: Bills - National Health Amendment (COVID-19) Bill 2021 - First Reading, Second Reading, Debate Adjourned
26 AUG 2021: REPS HANSARD: Adjournment - COVID-19: Dementia
26 AUG 2021: REPS HANSARD: Bills - Health Insurance Amendment (Enhancing the Bonded Medical Program and Other Measures) Bill 2021 - First Reading, Second Reading, Debate Adjourned
26 AUG 2021: REPS HANSARD: Bills - Australian Organ and Tissue Donation and Transplantation Authority Amendment (Governance and Other Measures) Bill 2021 - Returned from Senate
26 AUG 2021: REPS HANSARD: Adjournment - Health Care
26 AUG 2021: REPS HANSARD: Bills - Dental Benefits Amendment Bill 2021 - Debate Resumed, Second Reading, Third Reading
26 AUG 2021: REPS HANSARD: Statements by Members - COVID-19: Quarantine
26 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Hospitals
26 AUG 2021: REPS HANSARD: Statements by Members - COVID-19: Young People
26 AUG 2021: REPS HANSARD: Statements by Members - COVID-19: Vaccination
26 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Aged Care
26 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
26 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Quarantine
26 AUG 2021: REPS HANSARD: Statements by Members - Shortland Electorate: COVID-19 Vaccination
26 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Regional Australia
26 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19 - Vaccination
26 AUG 2021: SENATE HANSARD: Statements - Women's Health
26 AUG 2021: SENATE HANSARD: Questions Without Notice - Take Note of Answers - COVID-19
26 AUG 2021: SENATE HANSARD: Bills - National Disability Insurance Scheme Amendment (Improving Supports for At Risk Participants) Bill 2021 - First Reading, Second Reading, Debate adjourned
26 AUG 2021: SENATE HANSARD: Statements - COVID-19 - Quarantine
26 AUG 2021: SENATE HANSARD: Questions Without Notice - Additional Answers - COVID-19 - Vaccination
26 AUG 2021: SENATE HANSARD: Bills - Australian Organ and Tissue Donation and Transplantation Authority Amendment (Governance and Other Measures) Bill 2021 - Second Reading, Third Reading
26 AUG 2021: SENATE HANSARD: Statements - COVID-19 - Vaccination
25 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19: Vaccination
25 AUG 2021: SENATE HANSARD: Statements - COVID-19: Lockdowns
25 AUG 2021: SENATE HANSARD: Statements by Senators - COVID-19: Vaccination
25 AUG 2021: SENATE HANSARD: Matters of Public Importance - COVID-19
25 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19
25 AUG 2021: SENATE HANSARD: Statements - COVID-19: Vaccination
25 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Aged Care
25 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Quarantine
25 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
25 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
25 AUG 2021: REPS HANSARD: Questions Without Notice: Additional Answers - COVID-19: Vaccination
25 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: New South Wales
25 AUG 2021: REPS HANSARD: Statements By Members - Macquarie Electorate: Mental Health
25 AUG 2021: REPS HANSARD: Bills - National Disability Insurance Scheme Amendment (Improving Supports for At Risk Participants) Bill 2021 - Second Reading, Third Reading
25 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccine Manufacturing
25 AUG 2021: REPS HANSARD: Statements By Members - Ingham Institute for Applied Medical Research
24 AUG 2021: SENATE HANSARD: Statements - Autism
24 AUG 2021: SENATE HANSARD: Statements - COVID-19, Vaccination
24 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19, Vaccination
23 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19: Vaccination
24 AUG 2021: SENATE HANSARD: Statements - Victoria, COVID-19
24 AUG 2021: SENATE HANSARD: Statements - Yadu Health Aboriginal Corporation
24 AUG 2021: REPS HANSARD: Adjournment - COVID-19: Vaccination
v24 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
24 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Health Care
24 AUG 2021: REPS HANSARD: Statements By Members - COVID-19: Mental Health
24 AUG 2021: REPS HANSARD: Bills - National Disability Insurance Scheme Amendment (Improving Supports for At Risk Participants) Bill 2021 - Second Reading, Debate Interrupted
24 AUG 2021: REPS HANSARD: Statements By Members - COVID-19: Lockdowns
24 AUG 2021: REPS HANSARD: Adjournment - Medicare - COVID-19
24 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Morrison Government
23 AUG 2021: REPS HANSARD: Statements by Members - COVID-19
23 AUG 2021: REPS HANSARD: Statements by Members - COVID-19: Lockdowns
23 AUG 2021: REPS HANSARD: Statements by Members - Member for Dawson - COVID-19: New South Wales
23 AUG 2021: REPS HANSARD: Statements by Members - COVID-19: Vaccination
23 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination - COVID-19: Treatment
23 AUG 2021: REPS HANSARD: Statements by Members - COVID-19: Victoria
23 AUG 2021: SENATE HANSARD: Adjournment - COVID-19
23 AUG 2021: SENATE HANSARD: Statements - COVID-19: Vaccination
23 AUG 2021: REPS HANSARD: Adjournment - COVID-19: Lockdowns
23 AUG 2021: SENATE HANSARD: Questions Without Notice: Take Note of Answers - COVID-19 - Prime Minister
23 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19: Economy
23 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19
23 AUG 2021: SENATE HANSARD: Questions Without Notice - COVID-19: Vaccination
23 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Lockdowns
23 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Morrison Government
23 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
23 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19: Regional Australia
23 AUG 2021: REPS HANSARD: Questions Without Notice - COVID-19
South Australia
24 AUG 2021: SA COUNCIL HANSARD: Question Time - Repat Health Precinct
24 AUG 2021: SA COUNCIL HANSARD: Question Time - Patient Care, Royal Adelaide Hospital
24 AUG 2021: SA COUNCIL HANSARD: Question Time - Kindred Living Aged Care
24 AUG 2021: SA ASSEMBLY HANSARD: Answers to Questions - Aged Care
24 AUG 2021: SA ASSEMBLY HANSARD: Answers to Questions - Disability Services
24 AUG 2021: SA ASSEMBLY HANSARD: Bills - Voluntary Assisted Dying Bill 2020 - Assent
24 AUG 2021: SA ASSEMBLY HANSARD: Answers to Questions - Security Incidences At Public Hospitals
24 AUG 2021: SA ASSEMBLY HANSARD: Answers to Questions - Ambulance Ramping
24 AUG 2021: SA ASSEMBLY HANSARD: Answers to Questions - Indigenous Hearing Health
24 AUG 2021: SA ASSEMBLY HANSARD: Answers to Questions - SA Health Advertising Costs
Return to top
Court Cases
None this edition.
Return to top
New Regulations
Federal
Therapeutic Goods Amendment (Therapeutic Goods Advertising Code) Instrument (No. 4) 2021
Legislative Instrument - F2021L01179
The purpose of the Therapeutic Goods Amendment (Therapeutic Goods Advertising Code) Instrument (No. 4) 2021 ('the Amendment Instrument') is to add a reference to the Therapeutic Goods (Restricted Representations-HHD Group Pty Limited) (AZ) Permission 2021 ('the Permission') to subsection 6(2) of the Code. By adding a reference to the Permission in this provision, the Amendment Instrument has the effect that the Code does not apply to an advertisement that is made in accordance with the Permission.
Explanatory Statement
Food Standards (Proposal M1018 - Maximum Residue Limits (2020)) Variation
Legislative Instrument - F2021L01174
The Authority has approved a draft variation to Schedule 20 to vary maximum residue limits MRLs for residues of agricultural and veterinary chemicals in food commodities. Section S20-3 currently lists the MRLs for agricultural and veterinary chemicals which may occur in foods, however if an MRL is not listed for a particular agricultural or veterinary chemical food combination or there is no All other foods except animal food commodities MRL, there must be no detectable residues of that chemical in that food. This general prohibition means that, in the absence of a relevant MRL in the Code, the food may not be sold where there are detectable residues.
Explanatory Statement
Therapeutic Goods (Excluded Goods) Amendment (Personalised Medical Devices) Determination 2021
Legislative Instrument - F2021L01161
The Therapeutic Goods (Excluded Goods) Amendment (Personalised Medical Devices) Determination 2021 ('the Amendment Determination') is made under section 7AA of the Act and amends the Principal Determination. The Therapeutic Goods (Medical Devices-Specified Articles) Amendment (Personalised Medical Devices) Instrument 2021 ('the Amendment Instrument') is made under subsection 41BD(2B) of the Act and amends the Principal Instrument. The purpose of the Amendment Determination is to address concerns relating to the level, and impact, of regulation under the Act of certain lower risk personalised medical devices.
Explanatory Statement
Therapeutic Goods (Medical Devices - Specified Articles) Amendment (Personalised Medical Devices) Instrument 2021
Legislative Instrument - F2021L01160
The Therapeutic Goods (Excluded Goods) Amendment (Personalised Medical Devices) Determination 2021 ('the Amendment Determination') is made under section 7AA of the Act and amends the Principal Determination. The Therapeutic Goods (Medical Devices-Specified Articles) Amendment (Personalised Medical Devices) Instrument 2021 ('the Amendment Instrument') is made under subsection 41BD(2B) of the Act and amends the Principal Instrument. The purpose of the Amendment Determination is to address concerns relating to the level, and impact, of regulation under the Act of certain lower risk personalised medical devices.
Explanatory Statement
Human Services (Medicare) (Medicare Programs) Specification 2021
Legislative Instrument - F2021L01153
The Human Services (Medicare) (Medicare Programs) Specification 2021 (the 2021 Specification) repeals and replaces the Human Services (Medicare) (Medicare Programs) Specification 2019 (the 2019 Specification). Subsection 33(3) of the Acts Interpretation Act 1901 provides that where an Act confers a power to make, grant or issue any instrument of a legislative or administrative character, the power shall be construed as including a power exercisable in the like manner and subject to the like conditions (if any) to repeal, rescind, revoke, amend or vary any such instrument.
Explanatory Statement
ACT
Mental Health (Facility) Approval 2021 (No 1)
Notifiable instrument NI2021-507
Download
Mental Health (Facility) Approval 2021 (No 2)
Notifiable Instrument NI2021-504
Download
Public Health (Aged Care Workers COVID-19 Vaccination) Emergency Direction 2021
Notifiable Instrument NI2021-501
Download
Return to top
Proclamations
None this edition.
Return to top
Gazette Notices
None this edition.
Return to top
Consolidated Legislation
Therapeutic Goods Regulations 1990
Legislative Instrument Compilation - F2021C00839
SR 1990 No. 394 Regulations as amended, taking into account amendments up to Therapeutic Goods Legislation Amendment (2021 Measures No. 2) Regulations 2021.
Download
National Health (Highly Specialised Drugs Program) Special Arrangement 2021
Consolidated Legislation - F2021C00821
PB 27 of 2021 Arrangements as amended, taking into account amendments up to National Health (Highly specialised drugs program) Special Arrangement Amendment (August Update) Instrument 2021
Download
Return to top
New Bills
Federal
A Bill for an Act to amend the Australian Organ and Tissue Donation and Transplantation Authority Act 2008, and for related purposes
This Bill will amend the Australian Organ and Tissue Donation and Transplantation Authority Act 2008 (OTA Act) to transition the role of the Accountable Authority under the Public Governance, Performance and Accountability Act 2013 (PGPA Act) from the Board to the Chief Executive Officer (CEO). This change follows recommendations made by Dr Mal Washer, Chair of the Organ and Tissue Authority Board (the Board), to Minister Coulton to enable the Board to have a more strategic and advisory focus. This amendment will repeal the existing Board and create a new Advisory Board.
Reps: Intro 16/06/21, 2R 16/06/21, 11/08/21, Passed 11/08/21
Senate: Intro 12/08/21, 2R 12/08/21, 26/08/21, Passed 26/08/21
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedules 1 and 2 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 6 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
A Bill for an Act to amend the Dental Benefits Act 2008, and for related purposes
This Bill will amend the Dental Benefits Act 2008 (the Act) to remove the lower eligibility age restriction of 2 years to allow eligible children from 0 years of age to access the Child Dental Benefits Schedule (CDBS).
The CDBS operates under the Act to provide eligible children aged between 2-17 years access to up to $1,013 in benefits for basic dental services, with benefits capped over two consecutive calendar years. The CDBS has provided over $2.3 billion in benefits and delivered more than 38 million services to over 3 million Australian children since it commenced on 1 January 2014 (to 30 June 2021).
The Report on the Fourth Review of the Dental Benefits Act 2008 (the Review) recommended lowering the current eligibility age to one year of age. The feedback received by the Department from the key stakeholders advised their preference of removing the lower eligibility age restriction altogether enabling all children under 18 years of age to access the scheme if they meet the CDBS means test requirements.
By removing the lower eligibility age restriction altogether, it is estimated that each year an additional 300,000 children aged between 0 and 2 will become eligible for the program from 1 January 2022. It is estimated that each year 15% of children in this newly eligible age group (presenting with teeth) will access the scheme.
Reps: Intro 04/08/21, 2R 04/08/21, 11/08/21, 12/08/21, 26/08/21, Passed 26/08/21
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act - 1 January 2022.
A Bill for an Act to amend the Health Insurance Act 1973, and for related purposes
This Bill amends the Health Insurance Act 1973 (the Act) to implement improvements to the Bonded Medical Program (the Program) established under Part VD of the Act and to the administration of Medical Rural Bonded Scholarship (MRBS) contracts under section 19 of the Act.
The Government is committed to better distributing the medical workforce to regional, rural and remote communities, which on average have less access to doctors than people in metropolitan areas.
The Program provides a Commonwealth-supported place in a course of study in medicine at an Australian university in exchange for a participant completing a Return of Service Obligation (RoSO) working as a doctor in a regional, rural or remote community.
The Program commenced on 1 January 2020, replacing legacy contract-based schemes with new, simpler arrangements. In 2020 and 2021, new medical students at Australian universities have entered into this new Program. It is intended that participants in two legacy schemes, the MRBS Scheme and the Bonded Medical Places (BMP) Scheme can decide whether to opt in to the Program.
Amending the Act will provide the flexibility necessary to enhance implementation of the Program. The proposed amendments will address unintended consequences in the interests of participants and will also support achievement of the Commonwealth's Program objectives.
Reps: Intro 26/08/21, 2R 26/08/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedule 1 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 6 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
- Schedule 2 - The day after this Act receives the Royal Assent.
A Bill for an Act to amend the National Disability Insurance Scheme Act 2013, and for related purposes
The NDIS Act 2013 (the NDIS Act) provides a foundation for measures to support and protect NDIS participants at risk of harm. This Bill amends various provisions in the NDIS Act to improve the support and protections provided to NDIS participants who may be at risk of harm.
Following recent cases of abuse, neglect and exploitation of NDIS participants, the Government has considered a number of inquiries the effectiveness of NDIS safeguards in these cases, in addition to the Hon. Alan Robertson SC Independent Review of the adequacy of the regulation of the supports and services provided to Ms Ann- Marie Smith, an NDIS Participant, who died on 6 April 2020 (the Robertson Review), commissioned by the NDIS Commissioner.
The Bill will strengthen support and protections for people with disability by ensuring a clear and effective legislative basis for the NDIS Quality and Safeguards Commissioner's (Commissioner's) powers, compliance and enforcement arrangements, provider registration provisions and efficient information sharing across governments and government agencies.
On 17 Jun 2021, the Senate Selection of Bills Committee referred the Bill to the Community Affairs Legislation Committee for inquiry and report by 12 August 2021.
Reps: Intro 03/06/21, 2R 03/06/21, 23/08/21, 24/08/21, 25/08/21, Passed 25/08/21
Senate: Intro 26/08/21, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act - The day after this Act receives the Royal Assent.
A Bill for an Act to amend the National Health Act 1953, and for related purposes.
The Bill provides the Minister for Health with the power to enter into arrangements and make payments in relation to procuring COVID-19 vaccines, inclusive of boosters, and necessary consumables, and COVID-19 treatments.
Reps: Intro 26/08/21, 2R 26/08/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act - The day this Act receives the Royal Assent.
A Bill for an Act to amend the Paid Parental Leave Act 2010, and for related purposes.
The Bill amends the Paid Parental Leave Act 2010 (PPL Act) to provide that a person in receipt of an Australian Government COVID-19 payment, as specified by the Paid Parental Leave Rules, or the COVID-19 Disaster Payment will be considered to be performing qualifying work for the work test for Parental Leave Pay (PLP) and Dad and Partner Pay (DaPP).
The Paid Parental Leave (PPL) scheme is a Government-funded scheme consisting of PLP, an 18-week payment at the rate of the national minimum wage for eligible primary carers of newborn or recently adopted children; and DaPP, a two-week payment at the rate of the national minimum wage for eligible fathers and partners caring for newborn or recently adopted children.
The amendments made by this Bill are intended to assist people who have been affected by the economic impacts of the COVID-19 pandemic to be eligible for PLP and DaPP.
COVID-19 Payments as qualifying work
The Bill will support certain employees who have had their work hours reduced or who are stood down from their jobs due to the COVID-19 pandemic to continue to meet the work test for PLP or DaPP. The work test requires a person to have worked for at least 10 months of the 13 months prior to the birth or adoption of their child (or prior to their nominated start date for DaPP); and to have worked for at least 330 hours in that 10-month period with no more than a 12 week gap between two working days. This Bill would allow the time a person is receiving specified COVID- 19 payments, including the COVID-19 Disaster Payment, to count as qualifying work towards the work test for PLP and DaPP
Reps: Intro 25/08/21, 2R 25/08/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act - The day after this Act receives the Royal Assent.
South Australia
A Bill for An Act to amend the COVID-19 Emergency Response Act 2020 and to make a related amendment to the Local Government Act 1999.
The COVID-19 Emergency Response Act 2020 amended South Australia's legislation to temporarily adjust some legislative requirements that are difficult to satisfy during a pandemic. The COVID Act came into effect in April 2020 and will expire on 17 September 2021. This Bill proposes to extend the operation of the COVID Act to 28 days after the date on which all relevant declarations relating to the outbreak of COVID-19 within South Australia have ceased or 30 April 2022, whichever is the earlier.
LA: 1R 24/08/21, 2R 24/08/21, 25/08/21, Passed 25/08/21
LC: 1R TBA, 2R TBA, Passed TBA
LA: Final Stages TBA
Assent TBA, Act No. TBA
Commencement: This Act will come into operation on the day on which it is assented to by the Governor.
Tasmania
A Bill for An Act to amend the Guardianship and Administration Act 1995.
The Bill inserts provisions into the Guardianship and Administration Act 1995 (the Principal Act) to provide for the making and implementation of advance care directives in Tasmania.
The Bill provides that a person with decision-making ability may make decisions and give directions about their future health care by giving an advance care directive. The advance care directive may be given in writing or by any other means.
Witnessing requirements are prescribed in the Bill and witnesses are required to attest that the person giving the advance care directive is not acting under any form of duress or coercion.
The advance care directive may contain both binding and non-binding directives. Refusals or instructions to withdraw health care that are clear and unambiguous are binding. All other directives are non-binding. Non-binding directives must be complied with to the extent that it is reasonably practicable to do so.
LA: Intro 24/06/21, 2R 01/07/21, Passed 01/07/21
LC: Intro 01/07/21, 2R 25/08/21, 26/08/21, Passed TBA
Assent TBA, Act No. TBA
Commencement: This Act commences on a day to be proclaimed.
Return to top
New Acts
None this edition.
Return to top